Journal Article

Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3′-diindolylmethane

Xiaofei Chang, Gary L. Firestone and Leonard F. Bjeldanes

in Carcinogenesis

Volume 27, issue 3, pages 541-550
Published in print March 2006 | ISSN: 0143-3334
Published online September 2005 | e-ISSN: 1460-2180 | DOI:
Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3′-diindolylmethane

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


3,3′-Diindolylmethane (DIM), an indole derivative produced on consumption of broccoli and other cruciferous vegetables, has been shown to have multiple anticancer effects in both in vivo and in vitro models. The present study was carried out to clarify the mechanism of DIM's antiangiogenic activity. We found that DIM can inhibit vascular endothelial growth factor (VEGF)-induced cell proliferation and DNA synthesis in human umbilical vascular endothelial cells (HUVECs). Consistent with this inhibition, VEGF-induced extracellular signal-regulated kinase (ERK1/2) phosphorylation was greatly reduced. However, VEGF receptor phosphorylation induced by VEGF was not affected by DIM, indicating that DIM does not exert a direct and specific effect on the tyrosine kinase activity of this receptor. Further studies showed that DIM had a similar inhibitory effect on ERK1/2 phosphorylation induced by a variety of growth factors. Furthermore, Ras–GTP content, which dramatically increased after HUVECs were challenged by either individual growth factors or serum, was reduced by ∼80% with 25 μM DIM treatment, which in turn resulted in the reduced activities of Raf and MEK, culminating in the drop of ERK1/2 activation. Overexpression of constitutively active GTPase mutant, Ras G12V, in HUVECs reversed the inhibitory effect of DIM on ERK1/2 activation. In a rodent Matrigel plug model, the presence of DIM strongly reduced VEGF-induced neovascularization, indicating that DIM is active in vivo. These data provide evidence that DIM inhibits Ras signaling induced by VEGF and other growth factors, which interferes with its downstream biological effects necessary for angiogenesis.

Keywords: ATCC, American type culture collection; BP, benzo(a)pyrene; DIM, 3,3′-diindolylmethane; DMBA, dimethylbenz(a)anthracene; DMSO, dimethyl sulfoxide; ERK, extracellular signal-regulated kinase; Flk-1, fetal liver kinase-1; Flt-1, fms-like tyrosine kinase; HUVECs, human umbilical vein endothelial cells; I3C, indole-3-carbinol; KDR/Flk-1, kinase insert domain-containing receptor/fetal liver kinase-1; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; PAE, porcine aortic endothelial cell; RBD, Ras binding domain; VEGF, vascular endothelial growth factor

Journal Article.  7392 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.